168 related articles for article (PubMed ID: 4787947)
1. [Compounds stimulating central catecholamine receptors].
Grabowska M
Postepy Hig Med Dosw; 1973; 27(2):209-39. PubMed ID: 4787947
[No Abstract] [Full Text] [Related]
2. On the functional role of pre- and postsynaptic catecholamine receptors in brain.
Strömbom U
Acta Physiol Scand Suppl; 1975; 431():1-43. PubMed ID: 181950
[No Abstract] [Full Text] [Related]
3. Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
Kulkarni SK; Dandiya PC
Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):45-50. PubMed ID: 1233511
[TBL] [Abstract][Full Text] [Related]
4. The influence of antineoplaston A5 on the central dopaminergic structures.
Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
[TBL] [Abstract][Full Text] [Related]
5. Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity.
Andén NE; Strömbom U
Psychopharmacologia; 1974; 38(2):91-103. PubMed ID: 4533319
[No Abstract] [Full Text] [Related]
6. Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers.
Meltzer LT; Caprathe BW; Christoffersen CL; Corbin AE; Jaen JC; Ninteman FW; Pugsley TA; Serpa KA; Shih YH; Whetzel SZ
J Pharmacol Exp Ther; 1993 Sep; 266(3):1177-89. PubMed ID: 8103791
[TBL] [Abstract][Full Text] [Related]
7. Amantadine and apomorphine: interactions on striatal dopamine receptors.
Cox B
Proc West Pharmacol Soc; 1975; 18():162-7. PubMed ID: 1237137
[No Abstract] [Full Text] [Related]
8. The actions of amphetamine on neurotransmitters: a brief review.
Moore KE
Biol Psychiatry; 1977 Jun; 12(3):451-62. PubMed ID: 17437
[TBL] [Abstract][Full Text] [Related]
9. Influence of substances acting on the central adrenergic receptor on open field behaviour in rats.
Dandiya PC; Patni SK
Indian J Med Res; 1973 Jun; 61(6):891-5. PubMed ID: 4754333
[No Abstract] [Full Text] [Related]
10. An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
Papeschi R
Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):61-80. PubMed ID: 4276928
[No Abstract] [Full Text] [Related]
11. A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors.
Cox B; Kastin AJ; Schnieden H
Eur J Pharmacol; 1976 Mar; 36(1):141-7. PubMed ID: 4332
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine and dopamine-receptor stimulation.
Dray A; Oakley NR
J Pharm Pharmacol; 1976 Jul; 28(7):586-8. PubMed ID: 8616
[No Abstract] [Full Text] [Related]
13. Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
Papeschi R; Randrup A
Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):137-57. PubMed ID: 4800160
[No Abstract] [Full Text] [Related]
14. A neuropharmacological analysis of central nervous system catecholamine systems in development protein malnutrition.
Leahy JP; Stern WC; Resnick O; Morgane PJ
Dev Psychobiol; 1978 Jul; 11(4):361-70. PubMed ID: 566687
[TBL] [Abstract][Full Text] [Related]
15. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
Miller R; Horn A; Iversen L; Pinder R
Nature; 1974 Jul; 250(463):238-41. PubMed ID: 4368645
[No Abstract] [Full Text] [Related]
16. Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems.
Randrup A; Mogilnicka E
Pol J Pharmacol Pharm; 1976; 28(6):551-6. PubMed ID: 1034919
[TBL] [Abstract][Full Text] [Related]
17. The role of biogenic amines in the extra-pyramidal system.
Ernst AM
Acta Physiol Pharmacol Neerl; 1969 Jun; 15(2):141-54. PubMed ID: 5799067
[No Abstract] [Full Text] [Related]
18. Role of 5-HT in the action of some drugs affecting extrapyramidal system.
Gumulka W; Kostowski W; Czlonkowski A
Pharmacology; 1973; 10(6):363-72. PubMed ID: 4274062
[No Abstract] [Full Text] [Related]
19. Psychotropic actions of clonidine.
Lal H; Shearman GT
Prog Clin Biol Res; 1981; 71():99-145. PubMed ID: 6276904
[No Abstract] [Full Text] [Related]
20. The influence of insulin hypoglycemia on central dopaminergic structures of the rat.
Kleinrok Z; Ossowska G; Stelmasiak M; Juszkiewicz M
Pol J Pharmacol Pharm; 1983; 35(6):489-95. PubMed ID: 6377282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
